Yangtze Optical Fibre And Cable Joint Stock (601869.SH) shareholder Wuhan Yangtze Communication Industry Group intends to reduce its holding by no more than 1 million shares.

19:35 18/03/2026

Changfei Optoelectronics (601869.SH) issued an announcement that the shareholder Changjiang Communications intends to reduce its A-share holdings by no more than 1 million shares, or 0.12% of the total share capital of the company, through centralized bidding trading within 3 months after the disclosure of this announcement for its own operational and development needs.

Yangtze Optical Fibre And Cable Joint Stock (601869.SH) issued an announcement that the company's shareholder Wuhan Yangtze Communication Industry Group intends to reduce its A-share holdings through centralized competitive trading within 3 months after the disclosure date of this announcement, by no more than 1 million shares, not exceeding 0.12% of the total share capital of the company, for its own business development needs.

KINTOR PHARMA-B (09939): KX-826 1.0% solution achieves the main endpoint in Phase III critical clinical trial for treating male androgenetic alopecia in Chinese adult males.

QIANHAI HEALTH (00911) releases its performance for the year 2025, with a net profit of HK$5.941 million, representing a year-on-year increase of 353.2%.

SHANGHAI PECHEM (00338) set up a total provision for impairment of 397 million yuan in the 2025 fiscal year.

KINTOR PHARMA-B (09939): KX-826 1.0% solution achieves the main endpoint in Phase III critical clinical trial for treating male androgenetic alopecia in Chinese adult males.

QIANHAI HEALTH (00911) releases its performance for the year 2025, with a net profit of HK$5.941 million, representing a year-on-year increase of 353.2%.

SHANGHAI PECHEM (00338) set up a total provision for impairment of 397 million yuan in the 2025 fiscal year.